
Neparvis — sacubitril/valsartan 97/103 mg, film-coated tablets, 56 tablets
Brand: Novartis
+ delivery from €40
Neparvis 97/103 mg — sacubitril/valsartan, 56 film-coated tablets, a Novartis product.
Key information
Full description
Neparvis 97/103 mg — the higher tablet strength of the sacubitril and valsartan combination. The pack contains 56 film-coated tablets. The medicine is used for symptomatic heart failure with reduced ejection fraction in the age groups specified in the leaflet. The 97/103 mg strength is the higher dose in the product line and in many adult patients is used as the target maintenance dose after gradual titration. The maintenance dose depends on tolerability and the clinical situation. Blood pressure, kidney function and potassium are monitored during therapy; concomitant use with an ACE inhibitor is not permitted.
Frequently asked questions
How does Neparvis 97/103 mg differ from 24/26 and 49/51 mg?
It is the higher strength of the sacubitril and valsartan combination and is usually used after the titration stages.
Is 97/103 mg always a mandatory treatment target?
The target dose depends on tolerability, blood pressure, kidney function and the clinical situation of the individual patient.
Why must Neparvis not be combined with an ACE inhibitor?
The simultaneous effect increases the risk of angioedema, so the combination is contraindicated.
Which parameters are monitored at the high strength?
Blood pressure, kidney function and potassium levels are particularly important.
How to order
Tap the button for your preferred messenger. A manager will check availability, confirm the price and ask for your full delivery address.
This information is for reference only. Consult a doctor and read the official package leaflet before use.